0% found this document useful (0 votes)
8 views15 pages

6-Month UFAPS With FA 2021

Uploaded by

2020m002
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as XLSX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
8 views15 pages

6-Month UFAPS With FA 2021

Uploaded by

2020m002
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as XLSX, PDF, TXT or read online on Scribd
You are on page 1/ 15

6-MONTH USMLE STEP 1 SAMPLE SCHEDULE

Thanks for downloading our sample schedule! We don't suggest this is the ultimate schedule, but we offer it a starting point for yo

Ultimately, we recommend using a personalized, flexible,17.1


and Developmental
easily managed daily study plan
Anomalies; like what Cram Fighter offers, to ens
17.2
Day Event Subjects
Microbiology; Pathoma tasks
Study block #1 Spinal Cord Lesions; 17.3 Meningitis;
1 Nervous
Microbiology; 17.4
begins 17.4 Cerebrovascular
Cerebrovascular Disease Disease (Part
(Part 2 1
2 System
Nervous 17.5
of 2); Trauma,
17.5 17.6
Trauma, Demyelinating
17.6
Microbiology; of 2)
System Disorders
Demyelinating (PartDisorders
2 of 2); 17.7 (PartDementia
1 of 2)
3 Nervous
Microbiology; 17.7 Dementia and Degenerative
Microbiology; and
15.1 Degenerative
Anterior Disorders
Pituitary Gland, (Part
15.2 1 of
4 System
Nervous Disorders (Part 2 of 2); 17.8 CNS
Nervous
Microbiology; 2)
Posterior
15.3 Pituitary
Thyroid Gland, Gland;
15.4 15.3 Thyroid
5 System
System; Tumors
Gland, 15.4 Hyperthyroidism, 15.5
Nervous
Microbiology; Hyperthyroidism, 15.5
6 Endocrine
System; Hypothyroidism,
15.8 Parathyroid 15.6
Gland
Hypothyroidism, 15.6 Thyroiditis,Thyroiditis,
(Part 2 of 15.7
2);
15.7
Nervous
System Thyroid Neoplasia (Part 1 of 2)
Microbiology;
Endocrine 15.9 Endocrine Pancreas;
Thyroid Neoplasia (Part 2 of 2); 15.8 15.10
7 System;
Nervous
System
Microbiology; Adrenal
Parathyroid Cortex,
Gland 15.11
(PartAdrenal
1 of 2)
8 Catch-up day Endocrine
Microbiology
System;
Nervous Medulla
15.10 (Part
Adrenal 1 of
Cortex,2) 15.11 Adrenal
System
9 Endocrine
System; Medulla (Part 2 of 2); 7.1 Vasculitis
Microbiology;
System; (Part 1 of 2) (Part 2 of 2)
10 Endocrine
Endocrine 7.1 Vasculitis
Microbiology;
Cardiovascular 7.2 Hypertension (HTN); 7.3
System;
11 System;
Endocrine
System 7.4 Aortic Dissection and Aneurysm;
Microbiology;
Cardiovascular Arteriosclerosis
12 Cardiovascular
System; 7.5 Vascular Tumors; 8.1 Ischemic
Endocrine
System
Microbiology;
System
Cardiovascular 8.1
Heart Ischemic
DiseaseHeart(IHD)Disease
(Part 1 (IHD)
of 3)
13 System;
Endocrine 8.1
System (PartIschemic
2 of 3) Heart Disease (IHD)
14 Cardiovascular
System; (Part 3 of 3); 8.2 Congestive Heart
Microbiology;
Microbiology;
System
15 Cardiovascular
Cardiovascular Failure
8.4 (CHF);
8.4 Valvular
Valvular 8.3 Congenital
Disorders
Disorders (Part
(Part 2 1 Defects
of
of 2);
2)
Cardiovascular
Microbiology;
System
System 8.5 Endocarditis; 8.6 Cardiomyopathy,
16 System;
Cardiovascular
Microbiology; 8.7
18.1Cardiac
SkeletalTumors;
System18.1 (PartSkeletal
2 of 2);
17 Musculoskeleta
System;
Cardiovascular System
18.2 (Part 1 of 2)
Microbiology;
lMusculoskeleta
System
Microbiology; 18.2 Bone Tumors (Part 2 of 2)
Bone Tumors (Part 1 of 2); 18.3
18 System;
Cardiovascular 18.3 Joint (Part 2 of 2); 18.4 Skeletal
Cardiovascular
lMusculoskeleta
System Joint (Part 1 of 2)
19 System;
System; Muscle, 18.5 Neuromuscular Junction,
Microbiology;
lMusculoskeleta
System 9.1
18.6Nasopharynx,
Soft Tissue Tumors 9.2 Larynx; 9.3
20 Musculoskeleta
Musculoskeleta 9.3 Pulmonary Infections
ll System Pulmonary Infections (Part(Part
1 of22)of 2);
21 l System;
System; 9.4 Chronic Obstructive Pulmonary
Microbiology;
Respiratory
Respiratory Disease (Part 1 of 3)
22 Catch-up day Microbiology
Musculoskeleta
System
Microbiology;
System 9.4 Chronic Obstructive Pulmonary
23 lMusculoskeleta
System; 9.4 Chronic Obstructive Pulmonary
Microbiology; Disease (Part 2 of 3)
24 lRespiratory
System;
Musculoskeleta
9.5 Restrictive
Disease (Part 3Diseases
of 3); 9.5 (Part 2 of 2);
Restrictive
Microbiology;
System
Microbiology;
Respiratory 9.6 Pulmonary
Diseases (Part Hypertension,
1 of 2) 9.7
25 lMusculoskeleta
System; 9.8 Lung Cancer (Part 2 of 2); 9.99.8
Musculoskeleta
System Respiratory Distress Syndromes;
26 Respiratory
ll System; Pleura; 19.1 Inflammatory
System; LungInflammatory
19.1 Cancer (Part Dermatoses
1 of 2) (Part 2
System
Respiratory
Microbiology; Dermatoses
19.4 (Part 1 of 2)
27 Respiratory of 2);Disorders of Pigmentation
19.2 Blistering Dermatoses; and
System;
System; Skin Melanocytes;
Miscellaneous;
Microbiology; 19.3 Epithelial19.5 TumorsInfectious
28
Skin; Renal & 12.1
Miscellaneous; Congenital
Disorders; (Part 2 of 2);
12.1 Congenital 12.2
(Part 1 of
29 Microbiology;
Urinary System Acute
2) Renal Failure (ARF); 12.3
Skin
Renal & Urinary 12.5 Urinary Tract Infection, 12.6
Miscellaneous;
30 Microbiology;
Microbiology; Nephrotic
12.4
12.3 Nephritic Syndrome
Nephrotic Syndrome;
Syndrome (Part12.5
1 of Urinary
(Part 2)
2 of 2)
System
Renal & Urinary Tract
Nephrolithiasis, 12.7 Nephrolithiasis,
Chronic Renal
Miscellaneous;
Miscellaneous; Infection, 12.6
31 Microbiology;
System& Urinary Failure (Part 2 of 2); 12.8 Renal
Renal
Renal & Urinary 12.7 Chronic Renal Failure (Part 1 of
32 Miscellaneous;
System Neoplasia;
2) 12.9 Lower Urinary Tract
System;
Microbiology;
Respiratory 4.1 Primary Hemostasis and
33 Hematology &
Carcinoma;
4.1 Primary 4.1
Hemostasis and Related
Primary Hemostasis Related
Respiratory
System; Bleeding
Microbiology; Bleeding
and RelatedDisorders
Bleeding (Part 2 of
Disorders 3)
Oncology Disorders
4.2 Secondary Hemostasis and (Part 3 of 3); (Part
4.2
34 System;
Hematology
Respiratory & 1 of 3)
Secondary Hemostasis and Related
35 Hematology
Oncology
System; & Related Disorders (Part 2 of 2); 4.3
Microbiology; Disorders
Other Disorders(Part 1ofofHemostasis;
2) 4.4
Oncology
Hematology &
36 Catch-up day Microbiology
Respiratory Thrombosis (Part 1 of 2)
Microbiology;
Oncology 4.4 Thrombosis (Part 2 of 2); 4.5
37 System;
Renal & Urinary 4.5 Embolism
Embolism (Part(Part
1 of22)of 2); 5.1
38 Hematology & Anemia; 5.2 Microcytic Anemias Part
System;
Oncology
Hematology & 1 (Part 1 of 2)
Oncology
Microbiology;
Renal & Urinary 5.2 Microcytic Anemias Part 1 (Part 2
Microbiology;
39 System;
Renal & Urinary of
5.22); 5.2 Microcytic
Microcytic Anemias Anemias
Part 2Part(Part2 2
Microbiology;
Hematology & (Part 1 of 2)
40 System;
Renal & Urinary of
5.22); 5.2 Microcytic
Microcytic Anemias Anemias
Part 3Part(Part3 2
Oncology
Hematology & (Part 1 of 2)
41 System;
Microbiology; of 2); 5.3 Macrocytic Anemia (Part 1
Oncology
Hematology & 5.3 Macrocytic Anemia (Part 2 of 2);
42 Hematology
Microbiology;& of 2)
Oncology 5.4
5.5 Normocytic
5.5 Normocytic Anemia Anemias w/
Anemias w/
43 Oncology
Hematology &
Microbiology; Extravascular
Extravascular Hemolysis
Hemolysis
5.6 Normocytic Anemias w/ (Part 1
(Part 2 of
of 2)
2);
44 Oncology
Hematology & 5.6 Normocytic Anemias w/
Microbiology; Intravascular Hemolysis, 5.7 Anemia
45 Oncology
Hematology Intravascular Hemolysis,(Part 5.7 Anemia
Microbiology;& Due
Microbiology; 6.1
Due
to Underproduction
Leukopenia
to and Leukocytosis
Underproduction (Part
2 of 2);
1 of 2)
46 Oncology
Hematology 6.1 Leukopenia and Leukocytosis
Hematology &
Microbiology;& (Part
6.3
6.4
2 of 2);Leukemia
Chronic 6.2 Acute(Part
Myeloproliferative
(Part 1 ofLeukemia
2)
Leukemia;
Disorders2 of 2);6.3
47 Oncology
Oncology; & 6.5 Chronic
6.4 Lymphadenopathy
Myeloproliferative (Part 1 of
Disorders 2)
(LAD), 6.6
Hematology
Microbiology; (MPD) (Part 2 of 2) ;6.5
48 Gastrointestinal (MPD) (Part 1 of 2)
Oncology; & Lymphadenopathy (LAD),Lymphoma
Lymphoma, 6.7 Hodgkin 6.6
Hematology
System
49 Gastrointestinal (HL)
Oncology;
(Part 2 6.7
Lymphoma, of 2); 6.8 Plasma
Hodgkin Cell
Lymphoma
Microbiology;
System Disorders
6.8 Plasma (Dyscrasias),
Cell
(HL) (Part 1 of 2) Disorders 6.9
50 Catch-up day Gastrointestinal
Microbiology
Hematology & Langerhans Cell
(Dyscrasias), 6.9 Histiocytosis
Langerhans Cell (Part 1
System
51 Oncology;
Microbiology; of 2)
Histiocytosis (Part 2 of 2); 10.1 Oral
Microbiology;
Gastrointestinal Cavity; 10.2 Salivary Gland; 10.3
52 Gastrointestinal
Gastrointestinal 10.3 Esophagus (Part 2 of 2)
Microbiology;
System
System Esophagus (Part 1 of 2)
53 System;
Gastrointestinal 10.4 Stomach (Part 1 of 2)
Microbiology;
Reproductive 10.4 Stomach (Part 2 of 2); 10.5
54 System;
Gastrointestinal 10.5
Microbiology;
System SmallSmall
BowelBowel(Part (Part
1 of 2)2 of 2); 10.6
55 Reproductive
System; Appendix, 10.7 Inflammatory Bowel
Gastrointestinal
Microbiology;
System 10.6 Appendix, 10.7 Inflammatory
56 Reproductive
System; Disease
Bowel (Part
Disease 1 of 2)
(Part22of of2);
2);10.8
10.8
Gastrointestinal
Microbiology;
System 10.8 Colon (1) (Part
57 Microbiology;
Reproductive
System; Colon (1)
Colorectal (Part 1
Carcinoma of 2) (2);(Part
11.12 of 2);
Gastrointestinal
Reproductive
System 11.1 Exocrine Pancreas
58 Microbiology;
Reproductive
System; Exocrine
11.2 Pancreas (Part 1 ofTract;
2)
System;
Reproductive
System 11.3 Gallbladder
Liver: Jaundice and(Part
Biliary 2 of 2);
59 Reproductive
Behavioral/Psy 11.3
11.3 Liver:
Liver: Jaundice
Hepatitis; (Part
11.3 1 of 2)
Liver:
System;
Microbiology;
System
Microbiology;
chiatry; 11.3 Liver:& Cirrhosis
Cirrhosis Tumors (Part & Tumors
1 of 2)(Part 2
60 Behavioral/Psy
Reproductive
Behavioral/Psy
Gastrointestinal of 2); 13.1 Vulva (Part
13.1 Vulva (Part 2 of 2); 13.2 1 of 2) Vagina
61 chiatry;
System;
chiatry;
System
Microbiology;
Gastrointestinal 13.2
(Part Vagina
1 of 2) (Part 2 of 2); 13.3 Cervix;
62 Behavioral/Psy
Biochem, Cell 13.4 Endometrium and Myometrium
Biochem,
System
chiatry Cell
Bio, Genetics; 13.4
(Part Endometrium
1 of 3) and Myometrium
63 Bio, Genetics;
Microbiology;
Reproductive (Part 2 of 3)
64 Catch-up day Reproductive
Microbiology
Biochem,
System Cell 13.4 Endometrium and Myometrium
System
Microbiology;
65 Bio, Genetics;
Biochem, Cell (Part 3 of 3); 13.5 Ovary; 13.6
Microbiology;
Reproductive 13.6 Ovarian
Ovarian Tumors Tumors
(Part (Part
1 of 2) 2 of 2); 3.5
66 Bio, Genetics;
Biochem, Cell
Microbiology;
System - HHV-6, roseola (Herpesviridae)
67 Reproductive
Bio,
Biochem, Cell 13.7 Gestational Pathology
Genetics;
Microbiology;
System
Reproductive 14.1 Penis; 14.2 Testicle; 14.3
68 Bio, Genetics;
Biochem, Cell Testicular Tumors (Part 1 of 2)
Microbiology;
System
Reproductive 14.3 Testicular Tumors (Part 2 of 2);
69 Bio, Genetics;
Biochem, Cell 16.2
Microbiology;
System 14.4 Inflammatory
Prostate; 16.1Conditions;
Introduction16.3
70 Reproductive
Bio, Genetics; Benign Tumors and Fibrocystic
Biochem,
System Cell
71 Reproductive
Microbiology; Changes
Bio, Genetics; 16.4 Breast Cancer (Part 1 of 2)
System
Reproductive
Reproductive 16.4 Breast Cancer (Part 2 of 2); 2.3
72
System;
System
Microbiology; Primary Immunodeficiency
2.4 Autoimmune Disorders Part 1
73 Immunology 2.4 Autoimmune Disorders Part 1
Immunology
Microbiology; (Part 1 of 2)
74 (Part 2 of 2); 2.4 Autoimmune
Immunology
Microbiology;
75 Microbiology; 2.4 Autoimmune
Disorders Disorders
Part 2 (Part 1 of 3)Part 2
Immunology 2.4 Autoimmune
(Part 2 of 3) Disorders Part 2
Immunology;
76 Microbiology; (Part 3 of 3); 1.1 Growth Adaptations
Pathology - 1.1
77 Pathology (PartGrowth
1 of 2)Adaptations (Part 2 of 2);
General - 1.2 Cellular Injury (Part 1 of 3)
78 Catch-up day General
Microbiology
Microbiology;
79 Pathology - 1.2 Cellular Injury (Part 2 of 3)
General
Microbiology;
1.2 Cellular Injury (Part 3 of 3); 1.3
80 Pathology
Microbiology; -
Cell Death
1.3 Cell Death(Part(Part
1 of22)of 2); 1.4 Free
81 General
Microbiology;
Pathology -
Immunology; Radical
1.4 FreeInjury
Radical(Part 1 of(Part
Injury 2) 2 of 2);
82 General
Microbiology;
Pathology -
Immunology; 1.5 Amyloid
1.5 Amyloid (Part
(Part 2 1 of
of 2);
2) 2.1 Acute
83 Microbiology;
General
Pathology
Immunology; - Inflammation Part
2.1 Acute Inflammation Part 1 (Part 1 of1 3)(Part 2
84 Microbiology;
General
Pathology - 2.1
of 3)Acute Inflammation Part 1 (Part 3
Immunology;
85 General
Microbiology; of
2.13); 2.1 Acute
Acute Inflammation
Inflammation Part 2Part (Part2 2
Pathology -
86 Pathology (Part 1 of 2)
General - of
2.12); 2.1 Acute
Acute Inflammation
Inflammation Part 3Part (Part3 2
Pathology
General - (Part 1 of 2)
87 of 2); 2.2 Chronic Inflammation (Part 1
General
Pathology
88 Pathology -- 2.2
of 2)Chronic Inflammation (Part 2 of 2);
General
General; 2.5 Wound Healing (Part 1 of 2)
89 Pharmacology - 2.5 Wound Healing (Part 2 of 2); 3.1
Pharmacology
General; - Neoplasia (Part 1 of 2)
90 Pharmacology
General - 3.1 Neoplasia (Part 2 of 2); 3.2
Pathology 3.2
Carcinogenesis PartPart
Carcinogenesis 1 (Part
1 of22)of
General; - 1 (Part
91 General 2); 3.2 Carcinogenesis Part 2 (Part 1
Pathology -
92 Catch-up day Pharmacology - of 2)
General 3.2 Carcinogenesis Part 2 (Part 2 of
General;
93 2);
3.2 3.2 Carcinogenesis
Carcinogenesis PartPart 3 (Part
3 (Part 2 of1
Pathology
Pathology --
94 of 2)
2); 3.3 Tumor Progression (Part 1 of
General
General
Pathology - 3.3
2) Tumor Progression (Part 2 of 2);
95
General 3.4 Clinical
17.1 Characteristics
Developmental Anomalies; 17.2
96 Catch-up day Spinal Cord Lesions; 17.3 Meningitis;
Study block #2 Nervous 17.7
97 17.4 Dementia
17.5 Trauma, andDemyelinating
17.6
Cerebrovascular Degenerative
Disease; 17.5
begins System
Nervous Disorders
Disorders (Part
(Part 2
2 of
of 2);
2); 17.8
17.7 CNS
Dementia
98 Nervous Trauma,
15.3 17.6
Thyroid Demyelinating
Gland, 15.4
System Tumors;
and 15.1
Degenerative
Disorders Anterior
(Part 1 15.5 Pituitary
Disorders
of 2) Gland,
(Part 1 of
System;
Nervous Hyperthyroidism,
99 Nervous 15.2
2) Posterior Pituitary Gland; 15.3
Endocrine
System; Hypothyroidism, 15.6Hyperthyroidism,
Thyroiditis, 15.7
100 System; Thyroid Gland, 15.4
System
Endocrine Thyroid Neoplasia (Part 2 of 2); 15.8
Endocrine 15.5 Hypothyroidism,
15.10 Adrenal Cortex,15.6 15.11 Thyroiditis,
Adrenal
101 Nervous
System Parathyroid
15.7 Thyroid Gland; 15.9
Neoplasia(Part Endocrine
(Part11of of2)
2)
System; Medulla; 7.1 Vasculitis
102 Catch-up Day System;
Cardiovascular Pancreas7.1 Vasculitis (Part 2 of 2); 7.2
Endocrine
Endocrine
System
103 Hypertension
7.4 (HTN); and
Aortic Dissection 7.3 Aneurysm;
System;
System;
104 Endocrine Arteriosclerosis
8.1 Ischemic Heart Disease
7.5 Vascular Tumors; 8.1 Ischemic (IHD)
Cardiovascular
Cardiovascular
System;
Cardiovascular
System (Part
Heart
8.4 2 of
Valvular 2);
Disease 8.2 Congestive
(IHD) (Part
Disorders (Part12 Heart
of of2)2);
105 System
Cardiovascular
System; Failure
8.5 (CHF);
Endocarditis; 8.3 Congenital
8.6 Defects;
Cardiomyopathy,
106 Cardiovascular
Cardiovascular
System 8.4
Musculoskeleta
System; 8.7 Valvular
18.1
18.3 Skeletal
Cardiac Disorders
System
Tumors;
Joint (Part 2 of 2); (Part
(Part
18.118.4 21Skeletal
ofof2);
Skeletal 2)
107 System;
Cardiovascular
lMusculoskeleta
System 18.2 Bone
System (Part Tumors;
1 of 2) 18.3 Joint (Part 1
Muscle, 18.5 Neuromuscular Junction,
Musculoskeleta
System; of 2)
108 ll System 18.6 Soft Tissue
9.3 Pulmonary Tumors; (Part
Infections 9.1 2 of 2);
System;
Musculoskeleta
109 Musculoskeleta Nasopharynx,
9.4 Chronic 9.2 Larynx;
Obstructive 9.3
Pulmonary
Respiratory
ll System; 9.4 ChronicInfections
Obstructive Pulmonary
System; Pulmonary
Disease (Part (Part 1 of22)
110 Musculoskeleta
System
Respiratory 9.5
Disease (Part 1
Restrictive of
of 2)
2Diseases
2); 9.5(Part
Restrictiveof 2);
Respiratory
lSystem
System; 19.1
9.6 Inflammatory
Pulmonary Dermatoses; 19.2
111 Diseases (Part Hypertension,
1 of 2) 9.7
System
Respiratory
Musculoskeleta Blistering
Respiratory
19.4 Dermatoses;
Disorders Distress 19.3 Epithelial
Syndromes;
of Pigmentation 9.8
and
Musculoskeleta
112 lSystem
System;
Miscellaneous; Tumors;
Lung
Melanocytes 19.4(Part
Cancer; Disorders
9.9 Pleura
2 of of 19.5
2);
l System; Skin 12.3
12.5 Nephrotic
Urinary Syndrome
Tract Infection, (Part
12.6 2 of 1
113 Miscellaneous; Pigmentation and Melanocytes (Part
Miscellaneous; Infectious
Respiratory 2); 12.4 Disorders;
Nephritic
Nephrolithiasis,
12.1 Congenital;
Syndrome;
12.7 Chronic 12.5
Renal
114 Skin;
RenalRenal
System & of
& Urinary 12.22) Acute Renal
Urinary Failure
Tract2Infection, (ARF);
12.6 12.3
Urinary System Failure
Nephrotic (Part of
Syndrome 2); 12.8
(Part Renal
1 of 2)
;Renal
System & Nephrolithiasis,
115 Neoplasia; 12.9 12.7 Lower Chronic
UrinaryRenal Tract
Urinary Failure (Part 1 of 2)
116 Catch-up day Respiratory
Respiratory Carcinoma;
4.1 Primary 4.1 Primary
Hemostasis Hemostasis
and Related
System;
System; and Related Bleeding Disorders 2); (Part
117 System;
Hematology & Bleeding
Renal 4.2 Secondary Disorders (Part
Hemostasis 2 ofand 4.2
Hematology
& Urinary & 1 of 2)
Secondary Hemostasis and Related
118 & Urinary Related
Oncology
Renal
Oncology Disorders
Disorders (Part 2 of 2); 4.3
(Part5.1
1ofofAnemia;
2)
System; 4.5
Other Embolism;
Disorders Hemostasis; 5.2 4.4
System;
Renal & Urinary 5.2 Microcytic Anemias Part 1 (Part
119 Hematology & Microcytic Anemias Part 1 (Part 1 of2
Hematology
System; & Thrombosis
of 2); 5.2 Microcytic Anemias Part 2;
120 Oncology 2)
Oncology
Hematology & 5.2 Microcytic Anemias Part 3 (Part 1
Oncology of 2)
5.2 Microcytic Anemias Part 3 (Part 2
Hematology & 5.5 Normocytic Anemias w/
121 of 2); 5.3 Macrocytic
Extravascular Hemolysis; Anemia; 5.6 5.4
Oncology
Hematology & 5.6 Normocytic Anemias w/
122 Normocytic Anemia
Normocytic Anemias w/ Intravascular
Oncology & Intravascular Hemolysis, 5.7 Anemia
Hematology
123 Hematology & 6.2 Hemolysis,
DueAcute 5.7 Anemia
Leukemia
to Underproduction (Part Due2 of
(Part to22);
of6.3
2);
Oncology
Oncology; 6.4 Myeloproliferative
Underproduction
Chronic Leukemia; (Part
6.4 Disorders
1 of 2)
124 Hematology & 6.1 Leukopenia and Leukocytosis; 6.2
Gastrointestinal (MPD)
6.8
Acute (PartCell
Myeloproliferative
Plasma
Leukemia 2 ofDisorders
2); 6.5
Disorders
(Part 1 of 2)(MPD)
Oncology;
Hematology &
125 System Lymphadenopathy
(Part 1 of 2) 6.9 Langerhans
(Dyscrasias), (LAD), 6.6 Cell
Gastrointestinal
Oncology;
126 Gastrointestinal Lymphoma, 6.7 Hodgkin
Histiocytosis; 10.1 Oral Cavity; 10.2 Lymphoma
System
Gastrointestinal
System;
Gastrointestinal (HL)
10.3 Esophagus
Salivary Gland; 10.3 (PartEsophagus
2 of 2); 10.4 (Part
127 System
Reproductive
System; Stomach
1 of
10.4 2) (Part
Stomach 1 of
(Part 2)
2 of 2); 10.5
128 Gastrointestinal
System
Reproductive
System; Small Bowel 10.7 Inflammatory
10.6 Appendix,
129 System
Reproductive Bowel Disease; 10.8 Colon (1)
130 Catch-up day Gastrointestinal
Reproductive
System 10.8 Colorectal Carcinoma (2); 11.1
System;
System; Exocrine
11.3 Liver: Pancreas;
Jaundice11.2 (PartGallbladder
2 of 2);
131
Reproductive
Behavioral/Psy and
11.3 Biliary
Liver: Tract;
Hepatitis; 11.3 Liver:
11.3 Jaundice
Liver:
132 Reproductive
Reproductive
System (Part 1 of 2)
chiatry;
System; Cirrhosis
13.1 Vulva & (Part
Tumors; 2 of13.1 Vulva
2); 13.2 (Part
Vagina;
133 System;
Gastrointestinal 1 of 2)
Behavioral/Psy
Behavioral/Psy 13.3 Cervix (Part 1 of 2)
134 Biochem,
System
chiatry Cell 13.3 Cervix (Part 2 of 2); 13.4
chiatry;
Bio, Genetics; Endometrium and Myometrium
135 Biochem,
Biochem, Cell
Cell 13.5 Ovary; 13.6 Ovarian Tumors
Reproductive
Bio, Genetics;
136 SystemGenetics 13.7
Biochem,
Bio, Cell
14.3
Gestational Pathology; 14.1
Testicular Tumors; 14.4 Prostate;
Reproductive
Bio, Genetics; Penis; 14.2 Testicle
137 Biochem, Cell 16.1 Introduction; 16.2
Biochem,
System Cell
Reproductive 16.3 Benign Tumors andInflammatory
Fibrocystic
Bio,
Bio, Genetics;
Genetics; Conditions
16.4 Breast Cancer (Part 2 of 2); 2.31
138 System Changes; 16.4 Breast Cancer (Part
Reproductive Primary Immunodeficiency; 2.4
Microbiology;
139 of 2)
System
Reproductive 2.4 Autoimmune
Autoimmune Disorders
Disorders PartPart 1 1
1 (Part
Microbiology;
Microbiology;
140 System; (Part 2 of 2); 2.4 Autoimmune
of 2)Autoimmune Disorders Part 2
2.4
Immunology
Immunology;
141 Immunology Disorders
(Part 2 of 2);Part1.1 2 (Part
Growth 1 of 2)
Adaptations
Microbiology;
Pathology- 1.1 Growth
(Part 1 of 2) Adaptations (Part 2 of 2);
142 Pathology-
General
Microbiology; 1.2 Cellular Injury (Part 1 of 2)
General 1.2 Cellular Injury (Part 2 of 2); 1.3
143 Pathology-
Cell Death (Part 1 of 2)
144 Catch-up day General
Microbiology; 1.3 Cell Death (Part 2 of 2); 1.4 Free
145 Microbiology;
Pathology- Radical Injury; 1.5 Amyloid (Part 1 of
Immunology;
General 1.5
2) Amyloid
2.1 (Part 2 of 2);
Acute Inflammation 2.11Acute
Part (Part 2
146 Immunology;
Pathology- Inflammation Part 1
of 2); 2.1 Acute Inflammation (Part 1 ofPart
2) 2;
147 Pathology-
General
Immunology; 2.1
2.1 Acute
Acute Inflammation
Inflammation Part Part 3 3 (Part
(Part 1 2
148 General
Pathology- of
of 2)
2); 2.2 Chronic Inflammation
Pathology-
General
Pathology- 2.5 Wound Healing; 3.1 Neoplasia
149
General
General; (Part 1 of 2) (Part 2 of 2); 3.2
3.1 Neoplasia
150 Pathology-
Pharmacology-
General; Carcinogenesis
3.2 Carcinogenesis PartPart 1 2; 3.2
151 Pathology- 17.7
17.1 Dementia
Developmental and Degenerative
Anomalies;
General
Pharmacology-
General;
3.2 Carcinogenesis
Carcinogenesis
Disorders (Part Part
2 of
Part 3 (Part
3 (Part
2); 17.8 of217.2
1CNS 2)of
152 General Spinal
2); 3.3 Cord
Tumor Lesions;
Progression; 17.3 Meningitis;
3.4
Study block #3 Pharmacology- Tumors;
Nervous 17.4 15.1 Anterior Disease;
Cerebrovascular Pituitary Gland,
17.5
153 Nervous
Nervous Clinical Characteristics
begins General
System 15.2
Trauma,
15.9 Posterior Pituitary
17.6 Demyelinating
Endocrine Gland;
Pancreas (Part 2 of 15.3
System;
System;
154 Thyroid
Disorders;
2); 15.10 Gland,
17.7
Adrenal 15.4
DementiaHyperthyroidism,
Cortex, and
Endocrine
Endocrine 7.3
15.5 Arteriosclerosis
Hypothyroidism, (Part
15.6 215.11
of 2); 7.4
Thyroiditis,
155 Endocrine
System Degenerative
Adrenal Medulla;Disorders
7.1 (Part
Vasculitis; 1 of
7.22)
System; Aortic
8.4
15.7 Dissection
Valvular
Thyroid and
Disorders;
Neoplasia; Aneurysm;
8.5
15.8 7.5
System;
Cardiovascular 18.2 Bone
Hypertension Tumors
(HTN); (Part7.3 2 of 2); 18.3
156 Cardiovascular Vascular
Endocarditis;
Parathyroid Tumors;
8.6(Part
Gland; 8.1 Ischemic Heart
Cardiomyopathy,
15.9 8.7
Cardiovascular
System;
System;
Joint; 18.4 Skeletal
Arteriosclerosis
Disease (IHD); 8.2 1 ofEndocrine
Muscle,
Congestive2) 18.5Heart
157 System
System Cardiac
Pancreas
12.1 Tumors;
(Part
Congenital
Neuromuscular 1 18.1
of
(Part 2)
Junction, Skeletal
2 of 2); 12.2
18.6 Defects
Soft
Musculoskeleta
Musculoskeleta 9.4
9.8 Chronic
Failure
Lung(CHF); Obstructive
Cancer; 8.3 Pulmonary
Congenital
9.9 Pleura; 19.1 19.2
158 Musculoskeleta System;
Acute
Tissue 18.2
Renal
Tumors; Bone
Failure
9.1 Tumors
(ARF);
Nasopharynx, (Part
12.3 of
ll System Disease (PartDermatoses;
2 of 2); 9.5 Restrictive
l System;
System; Inflammatory
2)
Nephrotic
Larynx; Syndrome;
9.39.6
Pulmonary 12.4 19.2
Nephritic
Infections; 9.4
159 Respiratory
Miscellaneous; Diseases;
Blistering Pulmonary
Dermatoses; 19.3 Epithelial
Respiratory Syndrome;
Chronic 12.5
Obstructive Urinary Tract
Pulmonary
160 System
Respiratory Hypertension,
Tumors; 19.4 9.7 Respiratory
System
Miscellaneous; Infection,
Disease (Part12.6Disorders
1Nephrolithiasis,
of 2) of 12.7
161 System;
Renal Skin; Distress
& Urinary PigmentationSyndromes
and
Chronic Renal Failure Melanocytes; 19.5
Renal
System & Urinary Infectious Disorders; 12.1 Congenital
System (Part 1 of 2)
Miscellaneous;
Respiratory 12.8 Renal Neoplasia; 12.9 Lower
Respiratory
System; Renal Urinary Tract Carcinoma; 4.1 Primary
162 System;
& UrinaryRenal 4.3 Other Disorders
Hemostasis and Related of Hemostasis;
Bleeding
& Urinary
System;
Renal 4.4
& Urinary 5.5 Thrombosis;
Normocytic
Disorders;
5.2 4.5 Embolism;
Anemias
4.2 Anemias
Microcytic Secondary w/
Part 5.1
Hemostasis
2; 5.2
163
System;
System; Anemia;
Hematology & Extravascular
and Related
Microcytic 5.2 Microcytic PartAnemias
Hemolysis;
Disorders
Anemias 5.3 Part
3;5.6
164 Hematology
Hematology &
Oncology
Hematology & 6.2
&
1 Acute Leukemia
Normocytic
Macrocytic Anemias5.4
Anemia; (Part 2 of 2); 6.3
w/ Normocytic
Intravascular
165 Hematology
Oncology
Oncology & Chronic
Hemolysis,
Anemia Leukemia; 6.4
5.7 Anemia Due to
Oncology
Oncology; 6.8 Plasma Cell Disorders
166 Hematology & Myeloproliferative
Underproduction; Disorders
6.1 Leukopenia(MPD);and
Gastrointestinal (Dyscrasias),
6.5 6.9
Lymphadenopathy
Leukocytosis; 6.2 Langerhans
Acute (LAD),
LeukemiaCell
6.6
Oncology;
Gastrointestinal 10.4 Stomach (Part 22 of 2); 10.5
167 System Histiocytosis;
10.8 Colon
Lymphoma,
(Part of 2)(1)
1Bowel; 10.1
6.7 (PartOral
Hodgkin ofCavity;
2); 10.2
10.8
Lymphoma
Gastrointestinal
System; Small 10.6 Appendix, 10.7
168 Gastrointestinal
Reproductive Salivary
Colorectal
(HL) Gland; 10.3
Carcinoma Esophagus;
(2); 11.1 10.4
System
Reproductive Inflammatory Bowel Disease; 10.8
System;
System; Stomach
Exocrine
11.3 (Part
Pancreas;
Liver: 1
Cirrhosis of 2)
11.2 Gallbladder
& Tumors (Part 2
169 Behavioral/
System Colon (1) (Part 1 of 2)
Reproductive
Behavioral/Psy and
of Biliary
2); 13.1 Tract;
Vulva; 11.3
13.2 Liver:
Vagina;Jaundice;
13.3
170 Psychiatry;
System 13.4
11.3 Endometrium
Liver: Hepatitis; and Myometrium
11.3 Liver:
chiatry; Cervix;
Biochem, Cell (Part 13.4 Endometrium
2 of &2);Tumors
13.5 Ovary; and
13.6
171 Gastrointestinal Cirrhosis
Myometrium 1 (Part
(PartTesticle;2) 114.3
of 2)
of Gestational
Bio, Genetic; Ovarian
14.1 Tumors;
Penis; 14.2 13.7
172 Catch-up day Biochem,
System
Biochem, Cell
Cell Testicular
Reproductive Pathology Tumors; 14.4 Prostate; 16.1
Bio,
Bio, Genetic;
Genetic;
System
173 Introduction; 16.2 Inflammatory
16.4 Breast Cancer; 2.3 Primary
Reproductive
Microbiology;
174 Microbiology; Conditions; 16.3
Immunodeficiency; Benign
2.4 Tumors and
Autoimmune
System
Reproductive 2.4 Autoimmune Disorders Part 2; 1.1
Immunology; FibrocysticPart
Disorders Changes1
175 System;
Microbiology; Growth Adaptations; 1.2 Cellular
Pathology-
176 Microbiology;
Immunology
Pathology- Injury (Part 1Injury
1.2 Cellular of 2) (Part 2 of 2); 1.3 Cel
General
Immunology;
General 1.4 Acute
2.1 Free Radical Injury; Part
Inflammation 1.5 Amyloid;
2; 2.1
177 Immunology;
Pathology- 2.1 Acute Inflammation
Acute Inflammation Part 3; 2.2 Part 1
178 Pathology-
Pathology-
General
General; Chronic
2.5 WoundInflammation;
Healing (Part 2.52Wound
of
179 General
Pathology- 3.2 Carcinogenesis
Healing (Part 1 of 2)Part 2; 3.22); 3.1
Pharmacology - Carcinogenesis
General; Neoplasia; 3.2 Carcinogenesis
Part 3; 3.3 Tumor Part 1
180 General
Pharmacology- Progression; 3.4 Clinical
General Characteristics
hedule, but we offer it a starting point for your plan. Remember, everyone learns differently, and you will need to adjust your plan for your weak a

dy plan like what Cram Fighter offers, to ensure you cover all the Step 1 exam material you need to. Access a 7-day FREE trial of the Cram Fighte
SketchyMicro tasks First Aid (2021)
Embryology tasks
pp. 504-506; Pages Lecture length
1.1
1.1 -- Staphylococcus
Staphylococcus aureus aureus (Part(Part
2 Anatomy & Physiology (Part 8 34 minutes
1 ofof 2);
2) 1.2 - Staphylococcus Anatomy
epidermidis
1.3 pyogenes1.3 - 1
& saprophyticus;
- Streptococcus of 3) pp.&507-511
Physiology (Part
8 34 minutes
1.3 - Streptococcus 2 of 3) pp. 512-519
Streptococcus
(group (Partpyogenes
A strep)pyogenes 3 of (group
3); 1.4 A - Anatomy & Physiology (Part 8 34 minutes
(group
strep) A strep) (Part
(Part 1 ofagalactiae
Streptococcus 2 of
3) pneumoniae 3)
(group B 3 of 3) pp. (Part
Pathology 520-527
1 of 3) pp.
1.5 - Streptococcus 8 34 minutes
strep); 1.5 - Streptococcus
& viridans (Part 2 of 2); 1.6 - 528-535
Pathology (Part 2 of 3) pp.
pneumoniae &faecium
viridans 8 34 minutes
1.6 - Enterococcus
Enterococcus &(Part
faecium &1 of Pathology
faecalis 536-543 (Part 3 of 3) pp.
2.1
(Part- Bacillus
2)
faecalis 2) anthracis
1 of(Part 2 of 2); 2.1 & -cereus
Bacillus Otology
544-550;(PartOtology 8 33 minutes
2 of (Part
2) pp.1552-
of
(Part
anthracis 2 of & 2);cereus
2.2 - Clostridium
(Part 1 of 2) 2) pp. 551-551
2.3 - Clostridium botulinum (Part 2 552; Ophthalmology (Part 1 8 34 minutes
tetani; 2.3 - Clostridium botulinum
of 2); 2.5 - Clostridioides Difficile of 2) pp. 553-559 10 minutes
(Part- Clostridioides
2.5 1 of 2) Difficile (Part 2 Ophthalmology (Part 2 of 2)
(Part
of 12.5
of -2)Clostridium perfringens pp. Pharmacology (Part 2 of 2) 8 34 minutes
2.52); - Clostridium perfringens (Part 560-563; Pharmacology
(Part 1 of 2) pp.
(Part568-573;
1 of 2) Embryology
pp. 564-567 pp.
2
2.7 of-2); 2.6 - Corynebacterium
Listeria monocytogenes; 3.1 334-334; Anatomy pp. 335- 8 33 minutes
diphtheriae
-3.2 - Nocardia israelii;
Actinomyces asteroides 3.2 (Part
- 2 Physiology
335
(Part 1 of 2) pp.
8 35 minutes
Physiology
336-343 (Part 2 of 2) pp.
of 2); 4.1 -asteroides
Nocardia Neisseria (Part overview;
1 of 2) 4.2
4.2 - Neisseria meningitidis 344-345; Pathology (Part 1 of 8 33 minutes
- Neisseria meningitidis (Part(Part
1 of2 Pathology (Part 2 of 3) pp.
4.3
of - Neisseria gonorrhoeae (Part 3) pp.
Pathology346-351
(Part 3 of 3) pp. 8 34 minutes
2) 2); 4.3 - Neisseria gonorrhoeae 352-359
2 of-2);
(Part
5.1 1 of5.12)- Klebsiella
Klebsiella pneumoniae, 360-361; Pharmacology
Embryology (Part 2 of 2) pp.
pp. 8 34 minutes
pneumoniae, spp.,
Enterobacter Enterobacter
Serratia spp., 290-291; 362-365; Anatomy
Embryology pp.(Part
292- 1
Serratia marcescens 8 34 minutes
5.3 - Shigella
marcescens spp.;25.4
(Part of(Part
- ; 15.2
2); of -2) of 2) Physiology
292; pp. 288-289(Part 1 of 2)
Physiology (Part 2 of 2) pp.
Escherichia
Salmonella
5.4 - Escherichia coli (ETEC,
enteritidis EHEC)
& typhi
coli (ETEC, pp. 293-297 8 33 minutes
298-305
Pathology (Part 1 of 3) pp.
(Part
5.5
EHEC) 1 of
- Yersinia2) 2enterocolitica
(Part &
of 2); 5.5 - Yersinia 8 34 minutes
pestis (Part 2 & of pestis
2); 5.6(Part
- 306-313
enterocolitica 1 of 2) Pathology (Part 2 of 3) pp. 8 34 minutes
Campylobacter Pathology (Part 3 of 3) pp.
5.7 - Vibrio spp.jejuni; (Part 25.7 of -2);
Vibrio
5.8 - 314-321
Pharmacology (Part 2 of (Part
2)
spp. (Part 1 of 2) 322-323; Pharmacology 8 32 minutes
Helicobacter
5.9 - Proteus pylori mirabilis; 6.1 - pp. 330-332; Anatomy &
1 of 2) pp. 324-329 8 36 minutes
6.1 - Bordetella
Bordetella pertussis
pertussis (Part (Part
1 of 2) 2 Physiology (Part 1 of 2) pp.
Anatomy & Physiology (Part
of 2);
6.3 6.2 - Haemophilus
- Legionella pneumophila; 6.4 456-460 8 33 minutes
2 of 2) pp. 461-468
influenzae
- Pseudomonas aeruginosa (Part 10 minutes
6.4 - Pseudomonas aeruginosa
1 of 2)2 of 2); 7.1 - Bartonella Pathology (Part 1 of 3) pp.
(Part
7.1 - Bartonella henselae (Part 2 469-476 8 34 minutes
henselae Pathology (Part 2 of 3) pp.
7.3
of 2); 7.2 -(Part
- Francisella 1 tularensis
Brucella of 2)
spp.; 7.3 (Part
- 2 Pathology (Part 3 of 3) pp. 8 34 minutes
of 2); 7.4 - Pasteurella multocida; 477-484
Francisella tularensis (Part 1 of 2) 485-485; Dermatology (Part 1 8 34 minutes
8.1 Dermatology (Part 2 of 2) pp.
8.1 -- Mycobacterium
Mycobacterium tuberculosistuberculosis of 2) pp. 487-492
Pharmacology (Part 2 of 2)
(Part 1 tuberculosis 493-498; Pharmacology (Part 8 34 minutes
8.1 2 of
of 3)
(Part- Mycobacterium
3) pp. 500-502; Public Health
8.2 - Mycobacterium
(Part leprae (Part
3 of 3); 8.2 - Mycobacterium 1 of 2) pp. 499-500 8 33 minutes
2 of 2);(Part
9.1 - 1Borrelia Sciences Health Sciencespp.
(Part 1 of 4)
leprae of 2) burgdorferi; Public Public Health
(Part
Sciences (Part 8 34 minutes
9.2
9.3 - Leptospira
9.2 - Treponema interrogans
Leptospira interrogans
pallidum (Part (Part
(Part 2 2 259-264
of 4) pp. 265-272
Public Health Sciences (Part
2
1 of
of 2);2);
of 2)10.1 Treponema pallidum 4 of 4) pp. 281-281;
9.3--Chlamydia 8 34 minutes
3 of 4) pp. 273-280
Approaching the Organ
(Part
10.1 -1Chlamydia
trachomatis,of 2) Chlamydophila
trachomatis, 8 32 minutes
10.1 - Chlamydia
Chlamydophila trachomatis,
pneumoniae & Systems
Rapid pp. 284-285;
Review (Part 2 of Rapid
4)
pneumoniae & Chlamydophila 8 35 minutes
Chlamydophila
Chlamydophila pneumoniae
psittaci (Part &2 of Review
pp. (Part 1 of 4) pp. 713-
718-725
psittaci
10.3 (Part 1 of 3)vaginalis (Part Rapid Review (Part 3 of 4)
3) - Gardnerella
Chlamydophila psittaci (Part 3 of 717 Rapid Review (Part 4 of 4)
pp. 726-733
8 34 minutes
2
3);of10.2
2); 10.4 - Mycoplasma
- Coxiella burnetii; 10.3 - pp. 734-735; Respiratory
10.5 - Rickettsia overview 8 34 minutes
pneumoniae;
Gardnerella 10.5
vaginalis (Part(Part
- Rickettsia 1 of 2)2
Respiratory
(Part 1 of 4) (Part 2 of 4) pp.
pp. 683-688
of 2); 10.6(Part
overview - Rickettsia
1 of 2) prowazekii; 689-696 8 34 minutes
10.7 Respiratory (Part 3 of 4) pp.
1.1 - -Histoplasma
Rickettsia rickettsii
capsulatum 8 34 minutes
1.2 697-704
1.3 -- Blastomyces
Coccidioides immitis dermatitidis;
(Part 1.3
2 10 minutes
-ofCoccidioides
2.1 - Malassezia
2); immitis
furfur (Part
1.4 - Paracoccidioides (Part 12of of 2) Respiratory (Part 4 of 4) pp.
Embryology pp. 602-603; 8 33 minutes
2); 2.2 - Epidermophyton
brasiliensis; 2.1 - Malassezia spp., 705-712
Anatomy pp. 604-604;
Trichophyton
furfur (Part 1 of spp.,
2) Microsporum Physiology (Part 1 of 2) pp. 8 34 minutes
spp. (dermatophytes); 2.3 -
605-609
Sporothrix schenckii (Part 1 of 2)
2.3 - Sporothrix schenckii (Part 2
Physiology (Part 2 of 2) pp.
of
3.12); 3.1 - Candida
- Candida albicans albicans
(Part 2(Part
of 610-617 8 34 minutes
1 of 2) - Aspergillus fumigatus Pathology (Part 1 of 2) pp.
2);
3.2 3.2- Aspergillus fumigatus (Part 2 Pathology 8 34 minutes
618-625 (Part 2 of 2) pp.
(Part
3.3
of 2); 13.3
of -2)Cryptococcus
- Cryptococcus neoformans Embryology pp. 414-415;pp.
626-629; Pharmacology 8 34 minutes
3.4
(Part - Mucor
2 of 2);
neoformans (Part 1 of 2)spp.,
3.4 -Rhizopus
Mucor spp.
spp., Anatomy
630-633 pp. 416-419;
(mucormycetes) (Part 2 of 2); 3.5 Physiology 8 32 minutes
Rhizopus spp. (mucormycetes) Physiology (Part
(Part 21 of
of 2)
2) pp.
pp.
-1.1Pneumocystis
(Part- Picornaviridae
1 of 2) jirovecii; 1.1 -
overview (Part 420-421422-423; Pathology (Part 1 of 8 35 minutes
Picornaviridae
1.2 - Poliovirus overview (Part
(Picornaviridae) 1 of Pathology
3) pp. (Part 2 of 3) pp.
424-429
2 of 2); 1.2 - Poliovirus Pathology (Part 3 of 3) pp. 8 34 minutes
1.3
2)
(Part - Coxsackievirus
2 of 2); 1.3(Part A1&ofB2)
- Coxsackievirus 430-437
(Picornaviridae) 8 34 minutes
(Picornaviridae)
A
1.5 & -BHepatitis A (Part
(Picornaviridae) virus 2(Part 1.4 438-444; Pharmacology (Part
of 2);1 of
Pharmacology (Part
(Part 2
1 of 3) pp. 445-445 3 of
of 3)
-2)Rhinovirus (Picornaviridae);
(Picornaviridae) (Part 2 of 2); 1.6 1.5 -- Pharmacology 3) 8 33 minutes
pp.
pp. 446-453
454-454; Embryology pp.
Hepatitis
Norovirus/Norwalk A virus (Picornaviridae)
virus (Part 2 Anatomy (Part 2 of 2) pp. 8 34 minutes
1.7
1.8
(Part-
- Flaviviridae
Hepatitis C overview
virus
1 of 2) 1.7 - Flaviviridae 368-369; Anatomy (Part 1 of
(Caliciviridae);
of 2); 1.8 - Hepatitis Cofvirus 375-380; Physiology (Part 1 8 34 minutes
(Flaviviridae)
1.9 (Part
- Eastern/Western/Venezuelan 2 2); 1.9 - 2) pp. 370-374
Physiology (Part 2 of 2) pp.
overview
(Flaviviridae) (Part(Part
1 of 12)of 2) of 2) pp. 381-382
Eastern/Western/Venezuelan
equine encephalitis virus, Rubella 383-385; Pathology (Part 1 of 8 34 minutes
equine
virus encephalitis(Part
(Togaviridae) virus,2Rubella
of 2); 4) pp. 386-390 10 minutes
virus --(Togaviridae)
1.10
1.10 Coronavirus (Part 1 of 2)
Coronavirus Pathology (Part 2 of 4) pp.
8 34 minutes
(Coronaviridae)
(Coronaviridae)
1.11 - HIV Part 1: (Part
(Part 2 of
1 of 2)
Overview 2) 391-398
Pathology
Pathology (Part
(Part 34 of
of 4)
4) pp.
pp. 8 31 minutes
1.11 - HIV Part 1:
(Retroviridae) (Part 1 of 2) Overview 399-406
407-407; Pharmacology pp.
(Retroviridae)
1.12 - HIV Part(Part 2: Life 2 of 2); 1.12
Cycle (Part- 408-411; Embryology (Part 1 8 36 minutes
HIV Part Embryology (Part
(Part 2 of 3) pp.
2 of-2);
2.1 2.1 - Influenzavirus of 2) Embryology
2: Life
Influenzavirus Cycle (Part 1
of 3) pp. 636-638 3 of 3) pp. 8 34 minutes
2.1 - Influenzavirus (Part 3 639-646
(Orthomyxoviridae) 3) 647-647; Anatomy pp. 648-
1 of 3); 8 34 minutes
(Orthomyxoviridae)
2.2 - Measles virus, (Part
mumps 3) Physiology
2 ofvirus, (Part (Part
652; Physiology 2 of 2) pp.2)
1 of
2.2
2.2 -- Measles
Measles virus,
virus, mumps
mumps virus,
virus, 655-660;
pp. 653-654Pathology (Part 1 of 8 33 minutes
respiratory syncytial
respiratory syncytial virus,virus, Pathology (Part 2 of 3) pp.
respiratory
2.3 - Rabies virussyncytial virus, 3) pp. 661-662 8 34 minutes
parainfluenza
parainfluenza virus(Rhabdoviridae) 663-670
virus
parainfluenza
(Part virusEbolavirus, Pathology (Part 3 of 3) pp.
2.5 - Hantavirus, -California
2 of
(Paramyxoviridae)
(Paramyxoviridae)
(Paramyxoviridae)
2); 2.4 (Part
(Part 1
(Part 2 of
3 of 3)
of 3)
3); Pharmacology
671-678 pp. 679-682; 8 34 minutes
Marburgvirus
encephalitis (Filoviridae);
virus, Rift Valley 2.5fever
-
2.3 - Rabies virus (Rhabdoviridae) Psychiatry (Part 1 of 4) pp. 8 34 minutes
Hantavirus,
virus California(Part
(Bunyaviridae) encephalitis
2 of 2) ; Psychiatry
2.7
(Part- Rotavirus,
1Rift
of 2) Colorado tick 575-578 (Part 2 of 4) pp. 8 34 minutes
virus,
2.6 - Valley
Lymphocytic fever virus
fever
3.1 virus (Reoviridae);
- Herpes
(Bunyaviridae) simplex
(Part of 3.1
1virus - 1 579-586
2)type Psychiatry (Part 3 of 4) pp.
choriomeningitis virus Psychiatry (Part 4 of 4) pp. 8 33 minutes
Herpes
& 2 (Herpesviridae) (Part 2 of 2); 587-594
simplex virus type 1 & 2
(Arenaviridae)
(Herpesviridae) (Part 1 of 2) 595-600; Molecular (Part 1 of 8 34 minutes
3.2
3.2 -- Epstein–Barr
Epstein–Barr virus
virus Molecular (Part 2 of 3) pp.
3.2 - Epstein–Barr virus 3) pp. 34-35 8 34 minutes
(Herpesviridae)
(Herpesviridae) (Part
(Part 1
2 of
of 3)
3) 36-43
(Herpesviridae)
3.3 - Cytomegalovirus (Part 3 of 3); 3.3 -
10 minutes
Cytomegalovirus
(Herpesviridae) (Part (Herpesviridae)
2 of 2); 3.4 - Molecular (Part 3 of 3) pp.
(Part 1 of 2) Laboratory Techniques 8 34 minutes
Varicella-zoster
3.4 -- Varicella-zoster virus virus 34-35; Cellular pp. 46-51pp.
3.6 HHV-8, Kaposi's sarcoma 52-55; 8 32 minutes
(Herpesviridae)
(Herpesviridae) (Part
(Part 1 BK
of
of 2) Genetics (Part 2 (Part
Genetics of 2) 1 of60-
pp. 2)
3.7 - JC polyomavirus,
(Herpesviridae); 3.7 - 2JC 2)
pp. 56-59
polyomavirus 64; Nutrition
(Part(Part
2 of12)ofpp.
2) pp. 8 34 minutes
polyomavirus,(Polyomaviridae)
BK polyomavirus Nutrition 68-
3.8
(Part - Human
2 of 2); papillomavirus
3.8 - Human 65-67
72; Metabolism (Part 1 of 4) 8 35 minutes
(Polyomaviridae) (Part 1 of 2)
(Papillomaviridae)
papillomavirus (Papillomaviridae)(Part 2 of 2); Metabolism
pp. 73-75 (Part 2 of 4) pp.
3.9 8 33 minutes
(Part-- -Parvovirus
3.9
3.11 Parvovirus
1Smallpox
of 2) B19
B19 Cowpox
virus, 76-83
Metabolism (Part 3 of 4) pp.
(Parvoviridae)
(Parvoviridae)
virus, Molluscum (Part
(Part 2
1 ofof 2);
contagiosum2) 3.10 - Metabolism (Part 4 of 4) pp. 8 34 minutes
84-91
Adenovirus
virus (Poxviridae); (Adenoviridae)
3.12 - Hepatitis Basic 92-94;Bateriology (Part 2 of
Basic Bateriology 8 34 minutes
3.12 - Hepatitis B virus 2)
B virus (Hepadnaviridae) (Part 1 (Part 1 of 2) pp. 124-128 pp. 129-133; Clinical
3.12 8 32 minutes
of 3) - Hepatitis B (Part
(Hepadnaviridae) virus 2 of 3) Bacteriology (Part 1 of
Clinical Bacteriology 3) pp.
(Part 2
(Hepadnaviridae) (Part 3 of 3); 1.1 Clinical 134-136 Bacteriology (Part 3 8 36 minutes
1.1 - Giardia lamblia of 3) pp. 137-144
- Giardia lamblia (Part(Part
1 of22)of 2); of 3) pp. 145-150; Mycology 8 34 minutes
1.2 - Entamoeba histolytica Mycology (Part 2 of 2) pp.
1.3 - Cryptosporidium spp.; 2.1 - (Part 1 of 2) pp. 151-152
2.1 - Toxoplasma 2 of 153-154; Parasitology
(Part 2 of (Part
2) pp.1 8 34 minutes
Toxoplasma gondiigondii
(Part (Part
1 of 2) Parasitology
of 2)
2); 2.2 - Trypanosoma brucei; 2.3 161-161; Virology (Part 1 of pp. 155-160 8 33 minutes
2.3 - Naegleria
- Naegleria fowleri
fowleri (Part(Part
1 of22)of Virology (Part 2 of 3) pp. 169-
3) pp. 162-168 8 34 minutes
2); 3.1 - Trypanosoma
3.2 - Babesia; 3.3 - Plasmodium cruzi 176
10 minutes
Part (Part 1 of 2)Part 1 (Part 2 of Virology (Part 3 of 3) pp. 177-
3.3 - 1Plasmodium
177; Systems (Part 1 of 2) 8 34 minutes
2)
pp. 178-184
3.4 - Plasmodium Part 2:
Systems (Part 2 of 2) pp.
Treatment
4.1
3.5 and PPX;
5.1 -- Trichomonas
Leishmania
Enterobius 3.5 - (Part
Vaginalis
braziliensis
vermicularis, & 185-186; Antimicrobials (Part 8 34 minutes
Leishmania
2 of 2);
Ancylostoma5.1 -braziliensis
Enterobius
donovani (Partduodenale, &
2 of 2); 4.1Necator
- Antimicrobials (Part 2 of 3)
1 of 3) pp. 187-192 8 34 minutes
donovani
vermicularis,
Trichomonas
americanus, (Part 1 of 2)lumbricoides,
Ancylostoma
Vaginalis
Ascaris (Part 1 of Antimicrobials
pp. 193-200 (Part 3 of 3)
duodenale,
2)
Strongyloides Necator americanus,
stercoralis, pp. 201-204; Immunology 8 33 minutes
5.2 - Dracunculus
Ascaris lumbricoides,medinensis, Immunology (Part
(Part 1 of 4) pp. 2 of 4) pp.
95-98
Trichinella
Wuchereria spiralis (Part
bancrofti, 2 of 2);
Onchocerca 8 34 minutes
Strongyloides stercoralis, 99-106
Immunology (Part 3 of 4) pp.
5.2 - Dracunculus
volvulus, Toxocara medinensis,
canis, Loa 8 34 minutes
Trichinella
Wuchereria
6.1 spiralis
- Cestodes (Part
bancrofti,
(Part of12);
of
2Onchocerca2)loa- 107-114
(tissue nematodes) (Part 2 of6.2
2); Immunology (Part 4 of 4) pp.
8 34 minutes
volvulus,
Trematodes
6.1 - CestodesToxocara
(Part 1canis,
(Part of1 2) Loa loa
of 2) 115-122
Pathology (Part 1 of 4) pp.
6.2 - Trematodes
(tissue nematodes) (Part
(Part 2 of
1 of2)2) 8 31 minutes
205-212
Pathology (Part 2 of 4) pp.
8 24 minutes
213-220
Pathology (Part 3 of 4) pp.
Pathology 8 24 minutes
221-228 (Part 4 of 4) pp.
229-229; Pharmacology (Part 8 24 minutes
Pharmacology (Part 2 of 4)
1 of 4) pp. 231-237 8 24 minutes
pp. 238-245
Pharmacology (Part 3 of 4)
8 23 minutes
pp. 246-253
Pharmacology (Part 4 of 4)
5 24 minutes
pp. 254-258
24 minutes
23 minutes
Embryology pp. 504-506;
Anatomy
Anatomy & & Physiology
Physiology (Part
(Part 13 41 minutes
2 of 2) pp. 517-527;
1 of 2) pp. 507-516 13 41 minutes
Pathology
Pathology (Part
(Part 1
2 of
of 3)
3) pp.
pp.
Pathology
527-529 (Part 3 of 3) pp. 13 38 minutes
530-542
543-550; Otology pp. 551-
Ophthalmology (Part (Part
2 of 2) 13 40 minutes
552; Ophthalmology 1
pp.
of 2)556-563;
pp. Pharmacology
553-555 12 40 minutes
Pharmacology
(Part 1 of 2) pp.(Part 2 of 2)
564-567
pp. 568-573; Embryology pp.
334-334; Anatomy
Physiology pp.2)335-
(Part 2 of pp. 13 37 minutes
335; Physiology
341-345; Pathology (Part 1 of 2) 13 44 minutes
Pathology
pp. 336-340 (Part 2 of (Part
2) pp.1 of
2) pp. 346-353
Embryology
354-361; pp. 288-291;pp.
Pharmacology 12 40 minutes
Anatomy
362-365 pp. 292-292;
Physiology 13 40 minutes
Physiology (Part
(Part 21 of
of 2)
2) pp.
pp.
301-305;
293-300 (Part 2 of 2) pp.1 of
Pathology Pathology (Part 13 41 minutes
2) pp. 306-313
Pharmacology
314-323; (Part 2 of (Part
Pharmacology 2) 13 40 minutes
pp.
1 of 327-332;
2) pp. Anatomy
324-326
Anatomy & Physiology (Part &
13 40 minutes
Physiology (Part 1 of 2) pp.
2 of 2) pp. 463-468;
456-462 12 40 minutes
Pathology
Pathology (Part
(Part 12 of
of 2)
2) pp.
pp.
469-474
Dermatology pp. 487-498; 12 39 minutes
475-486
Pharmacology
Pharmacology (Part (Part 2 1 of
of 2)
2) 14 42 minutes
pp. 501-502;
pp. 499-500 Public Health
12 40 minutes
Sciences
Public (PartSciences
Health 1 of 2) pp.
Approaching
259-268 the Organ (Part 13 40 minutes
2 of 2) pp. 269-281
Systems pp. 284-285;
13 41 minutes
Respiratory (Part 1 of 3) pp.
683-693
Respiratory
Respiratory (Part
(Part 32 of
of 3)
3) pp.
pp.
707-712; 13 40 minutes
694-706 Embryology pp.
602-603; Anatomy
Physiology pp.2);
(Part 2 of 604- 12 39 minutes
604; Physiology
Pathology (Part
(Part 2(Part
1 of
of 2) 1 of 2)
2) pp.
pp. 13 41 minutes
Pathology
pp. 605-607
618-620 Pharmacology pp.
621-629; 13 41 minutes
630-633
Embryology pp. 414-415;
Anatomy pp. 416-419;
Physiology pp. 420-423; 13 40 minutes
Pathology
Pathology (Part (Part 2 1 of
of 3)
3) pp.
pp.
Pathology (Part 3 of 3) pp. 12 40 minutes
427-438
424-426
Pharmacology
439-444; Pharmacology (Part 2 of (Part
2); 13 40 minutes
Embryology
1 of 2) pp.(Part
Anatomy pp.
445-451 368-369;
2 of 2) pp. 13 41 minutes
Anatomy (Part 1 of 2)pp.
378-380; Physiology pp.381-
370-377 12 36 minutes
385; Pathology
Pathology (Part (Part 1 of 3)
Pathology
pp. 386-389 (Part 2 3 of
of 3)
3) pp.
pp. 13 44 minutes
390-402
403-407; Pharmacology pp.
Embryology (Part 2 of (Part
2) pp.1 13 40 minutes
408-411; Embryology
640-647;
of 2) pp. Anatomy
636-639
Physiology pp. 653-660; pp. 648- 13 38 minutes
652
Pathology (Part 1 of 3) pp. 12 41 minutes
661-664
Pathology
Pathology (Part (Part 2 3 of
of 3)
3) pp.
pp. 13 42 minutes
665-677
678-678; Pharmacology pp.
13 40 minutes
679-682;
PsychiatryPsychiatry
(Part 2 of (Part3) pp.1 of
3) pp.
Psychiatry575-582(Part 3 of 3) pp. 13 41 minutes
583-595
Molecular (Part 2 of (Part
596-600; Molecular 2) pp.1 of 12 38 minutes
41-45;
2) Cellular
pp. 34-40
Laboratory pp. 46-51;
Techniques (Part 13 42 minutes
Laboratory Techniques
2 of 2) pp. 54-55; Genetics (Part
1 of 2)
Nutrition pp. 52-53
(Part 2 of 2) pp. 67- 13 40 minutes
pp. 56-64; Nutrition (Part 1 of
72; Metabolism
2) pp. 65-66 (Part 1 of 3) 13 41 minutes
Metabolism
pp. 73-79 (Part 2 of 3) pp.
Metabolism (Part 3 of 3) pp. 12 41 minutes
80-91
92-94; Basic Bateriology pp. 13 40 minutes
Clinical
124-133Bacteriology
Clinical Bacteriology (Part (Part 1 2 13 40 minutes
of 2) pp. 134-146
of 2) pp. 147-150; Mycology
Parasitology 12 41 minutes
pp. 151-154; (Part 2 of 2) pp.
Parasitology
159-161;
Virology (Part 2 of 2) pp.1172-
(Part 1 of Virology
2) pp. (Part
155-158 of 13 40 minutes
2) pp. 162-171
177; Systems (Part 1 of 2) 13 40 minutes
pp. 178-184
Systems (Part 2 of 2) pp.
185-186; Antimicrobials
Antimicrobials (Part 2 of (Part
2) 13 40 minutes
1 of198-204;
pp. 2) pp. 187-197Immunology 12 41 minutes
Immunology
(Part 1 of 3) pp. (Part 2 of 3) pp.
95-99
Immunology (Part 3 of 3) pp. 13 40 minutes
100-112
113-122; Pathology (Part 1 of 13 37 minutes
Pathology
3) pp. 205-207 (Part 2 of 3) pp.
Pathology 13 43 minutes
208-220 (Part 3 of 3) pp.
221-229; Pharmacology (Part 12 41 minutes
Pharmacology
1 of 3) pp. 231-233 (Part 2 of 3)
13 40 minutes
1.1 - Staphylococcus
1.3 - Streptococcus pyogenes aureus; 1.2 - pp. 234-246
Pharmacology (Part 3 of 3)
Staphylococcus epidermidis 12 39 minutes
(group A strep) (Part 2 of 2); & 1.4 - Embryology
pp. 247-258 pp. 504-506;
saprophyticus; 1.3 - Pathology
Anatomy &pp. 528-550;
Physiology
(Part 2 pp. 24 1 hour
Streptococcus agalactiae (group B Ophthalmology of 2)
2.6
2.2 -
- Corynebacterium
Streptococcus
Clostridium pyogenes
tetani; 2.3(group- A Otology
507-527
pp. pp.
556-563; 551-552;
Pharmacology
strep); 1.5 - Streptococcus 28 1 hour
diphtheriae;
strep) 12.7
(Part botulinum;-2)Listeria Ophthalmology (Part 1 of 2)
Clostridium
4.3 - Neisseria
pneumoniae &ofviridans;
gonorrhoeae; 2.5
1.6- - 5.1 - pp. 564-573;
Physiology Embryology
(Part 2 of 2) pp. pp.
25 1 hour
monocytogenes;
6.4 - Pseudomonas
Clostridioides
Klebsiella 3.1
Difficile;
pneumoniae, -
aeruginosa
2.5 - pp. 553-555
334-334; Anatomy pp. 335-
Enterococcus faecium & faecalis; Embryology 341-345; Pathology pp. 288-291;pp. 346-
Actinomyces
(Part 2 of
Clostridium
Enterobacter
2.1 - 2);
Bacillus israelii;
7.1
perfringens
spp., -
anthracis 3.2&-cereus 335;
Bartonella
Serratia AnatomyPhysiology
pp. (Part
292-292; 1pp.
of 2) 25 1 hour
5.4 Escherichia coli 4.1
(ETEC, 361; Pharmacology
Pathology (Part 2 of 2) pp. 362-
Nocardia
henselae;
marcescens; asteroides;
7.2 - Brucella -
spp.; 7.3 - pp. 336-340 26 1 hour
5.9 - Proteus
EHEC)
Neisseria(Part 25.2
overview; of -2);
mirabilis;Salmonella
5.56.1
4.2
-
--- Yersinia
Physiology
Public
365
314-323; Health pp.Sciences
293-305;(Part
Pharmacology pp.
Francisella
enteritidis
Bordetella &tularensis;
typhi;
pertussis;
enterocolitica & 5.3
pestis; 7.4
-
6.2 5.6 -
Shigella
- Pathology
2 of 2)
324-332; pp. (Part
269-281;
Anatomy 1 of&2) pp. 25 1 hour
Neisseria
5.4 -meningitidis
Pasteurella multocida; Anatomy & Physiology (Part
spp.;
Haemophilus
Campylobacter jejuni; 8.1
Escherichia
influenzae; 5.7 --(ETEC,
coli6.3 -
Vibrio 306-313
Approaching
Physiology
Dermatology
2 of 2) pp. the
(Part
pp. 1
462-468; Organ
of 2) pp.
487-498; 25 1 hour
Mycobacterium
EHEC) (Part
Legionella
8.1 - 1 tuberculosis
of
pneumophila;
Mycobacterium 2) 6.4
tuberculosis (Part
- Systems
spp.; 5.8 - Helicobacter pylori
1 of 2)2 of 2); 8.2 Pathology pp. 469-486Rapid
456-461
Pharmacology pp. 284-285;
pp. 499-502;
26 1 hour
Pseudomonas
(Part aeruginosa
- Mycobacterium (Part 1 Public
ReviewHealth(Part 1Sciences
of 2) pp.(Part
713-
of 2) 9.1 - Borrelia burgdorferi; 722
leprae; 1 of 2) pp. 259-268 25 1 hour
9.2 - Leptospira interrogans; 9.3 -
Treponema pallidum (Part 1 of 2)
9.3 - Treponema pallidum (Part 2
10.3
of 2);-10.1 Gardnerella
- Chlamydia vaginalis; 10.4 Rapid Review (Part 2 of 2)
1.2 - Blastomyces dermatitidis; 1.3 Respiratory (Part 2 of 2) pp.
-trachomatis,
Mycoplasma Chlamydophila 10.5
pneumoniae; - pp. 723-735; Respiratory 26 1 hour
-Rickettsia
Coccidioides 696-712; Embryology pp.
pneumoniae & immitis;
overview; 10.6
Chlamydophila1.4- - (Part 1 of Anatomy
Physiology
602-603; 2)(Part
pp. 683-695
2 of
pp.2)604-
pp. 25 1 hour
Paracoccidioides
Rickettsia
2.3 - Sporothrix
psittaci; prowazekii;
10.2 brasiliensis;
schenckii;
- Coxiella 10.7 - 2.1
3.1
burnetii - - Embryology pp. 414-415;
610-617; Pathology pp.
604; Physiology (Part 1 of 2) 618-
Malassezia
3.3 - Cryptococcus
Rickettsia
Candida furfur; 2.2
rickettsii;
albicans; 1.1-- -
neoformans
3.2 Anatomy pp. 416-419; 24 1.5 hours
1.3 - Coxsackievirus A 3.3
&B 629; Pharmacology
Pathology
pp. 605-609 (Part 2 of pp. 630-
2) pp.
Epidermophyton
(Part
Histoplasma
Aspergillus 3.4 -spp.,
2 of 2);fumigatus;
capsulatumMucor spp.,
- Physiology pp. 420-423; pp. 27 1 hour
(Picornaviridae); 1.4Microsporum
- Rhinovirus 633
441-444; Pharmacology
Trichophyton
Rhizopus
1.8 - Hepatitis
Cryptococcus spp.spp.,
C(mucormycetes);
virus
neoformans (Part 1 Anatomy
Pathology (Part21ofof2)2)pp.
(Part pp.
pp.
(Picornaviridae); 445-454; Embryology 25 1.5 hours
spp.
3.5
of 2) - (dermatophytes)
Pneumocystis
(Flaviviridae); 1.9 - - Hepatitis
1.5 jirovecii; 1.1A- Pathology
368-369; Anatomy (Partpp.
424-440
379-380; (Part
Physiology2 of 2)
pp. 1381-
of
virus (Picornaviridae);
Picornaviridae
Eastern/Western/Venezuelan overview; 1.61.2 - - 405-407; Pharmacology pp. 26 1 hour
1.10
2.3 - - Coronavirus
Rabies virus 385;
2) pp.Pathology
370-378 (Part 1 of 2)
Norovirus/Norwalk
Poliovirus
equine encephalitis virus
(Picornaviridae)virus, 24 1.5 hours
(Coronaviridae)
(Rhabdoviridae);
2.1 - Influenzavirus
(Caliciviridae); (Part
1.7 2.4
- of Rubella
2); 1.11 pp.
-2Ebolavirus,
Flaviviridae
408-411;
386-404Embryology pp.
virus (Togaviridae); 1.10 - Physiology
636-647; pp. 653-660;
Anatomy pp. 648-
-(Orthomyxoviridae);
HIV Part 1: Overview
Marburgvirus
overview (Filoviridae);
2.2 - 2.5 -
Measles Pharmacology pp. 679-682; 26 1 hour
Pathology pp. 661-678
Coronavirus
(Retroviridae);
Hantavirus,
virus, mumps
(Coronaviridae)
1.12 -respiratory
California
virus, HIV Part 2: Psychiatry (Part 1 of 2)
encephalitis(Part Psychiatry
652 (Part 2 of
2)
pp.
pp. 26 1 hour
2.7
1 of-Cycle
Life 2)Rotavirus, Colorado tick 597-600; Molecular pp. 34-
virus,
syncytial Riftvirus,
Valleyparainfluenza
fever virus virus 575-596
fever virus (Reoviridae) (Part 2 of 45; Cellular pp. 46-51; 25 1 hour
(Bunyaviridae); 2.6 - Lymphocytic Laboratory
(Paramyxoviridae)
2); 3.1 - Herpes simplex Laboratory Techniques
Techniques (Part (Part
3.3 - Cytomegalovirus
choriomeningitis virus virus type 2 of 2) pp. 55-55; Genetics
1 & 2 (Herpesviridae);
(Herpesviridae); 3.2
3.4- -Rotavirus, -
Varicella- 1 of 2) pp. 52-54
3.11
3.7 - -JC Smallpox
(Arenaviridae);polyomavirus, virus,
2.7 Cowpox
BK pp. 56-64; Nutrition
Metabolism (Part 2 ofpp.2)65-pp. 26 1 hour
Epstein–Barr
zoster
virus,
Colorado virus
Molluscum
tick virus
(Herpesviridae);
fever contagiosum
virus 3.5 -
polyomavirus (Polyomaviridae); 72; Metabolism
Clinical
81-94; (Part
Bacteriology
Basic Bateriology1 of134-
pp. 2)
pp. 24 1 hour
(Herpesviridae);
HHV-6,
virus roseola
(Poxviridae);
(Reoviridae) (Part 3.3 - 2)
(Herpesviridae);
3.12
1 of - Hepatitis
3.8 - Human papillomavirus pp. 73-80
150; Mycology pp. 151-154;
124-133
Cytomegalovirus
3.6
B -- HHV-8,
virus (Hepadnaviridae);(Herpesviridae)
Kaposi's sarcoma 1.11.3
- - Parasitology (Part 1 of 2) pp. 26 1.5 hours
(Papillomaviridae);
1.2
3.4
(Part Entamoeba
Plasmodium
1 of 2) 3.9
Part -
histolytica;
2:
(Herpesviridae)
Giardia lamblia Systems
155-159 (Part 2 of22)ofpp. 26 1 hour
Parvovirus
Cryptosporidium
Treatment
2.3 - Naegleria B19PPX
and (Parvoviridae);
spp.;
fowleri 2.1 2- of
(Part
(Part 2); Parasitology
2 of 186-186;
(Part
Antimicrobials
2) pp.
pp.
3.10
3.5 - -Leishmania
Toxoplasma
2); 3.1 Adenovirus gondii;
- Trypanosoma (Adenoviridae)
2.2cruzi;
-
braziliensis & - Immunology
3.2 (Part 2 of 2) pp.1 25 1 hour
187-204; Immunology (Part
Trypanosoma
donovani;
Babesia; 3.3 4.1- -brucei; 2.3 - Part 1; 101-122; Pathology (Part 1 of
Trichomonas
Plasmodium 25 1.5 hours
5.2 of 2) pp. 95-100
Pathology (Part 2 of 2) pp.
3.4 -- Dracunculus
Naegleria
Vaginalis; fowleri medinensis,
(Part
5.1 - Enterobius
Plasmodium Part 1
2:of 2) 2) pp. 205-207
208-229; Pharmacology (Part 26 1 hour
Wuchereria
vermicularis,
Treatment bancrofti,
and Ancylostoma
PPX (Part Onchocerca
1 of 2) Pharmacology
1 of 2) pp. (Part 2 of 2)
231-234
volvulus,
duodenale, Toxocara
Necatorcanis, Loa loa
americanus, 24 1 hour
pp. 235-258
(tissue nematodes);
Ascaris lumbricoides, 6.1 -
Cestodes;
Strongyloides 6.2 stercoralis,
- Trematodes
Trichinella spiralis
djust your plan for your weak areas, if you fall behind, need catch-up days, etc.

y FREE trial of the Cram Fighter study schedule planner at www.cramfighter.com. Good luck!
UWorld questions Book Study Hours Lecture Study Hours QBank Study Hours
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1

10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1

10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1

10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1

10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1

10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1

10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1

10 2 1 1
10 2 1 1
10 2 1 1

40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2

40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2

40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2

40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2

40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2

40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2

You might also like